- Home
- NAT vs EYPT Comparison
NAT vs EYPT Comparison
Compare NAT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAT
- EYPT
- Stock Information
- Founded
- NAT 1995
- EYPT 1987
- Country
- NAT Bermuda
- EYPT United States
- Employees
- NAT N/A
- EYPT N/A
- Industry
- NAT Marine Transportation
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- NAT Consumer Discretionary
- EYPT Industrials
- Exchange
- NAT Nasdaq
- EYPT Nasdaq
- Market Cap
- NAT 543.9M
- EYPT 594.5M
- IPO Year
- NAT 1997
- EYPT 2005
- Fundamental
- Price
- NAT $2.56
- EYPT $8.00
- Analyst Decision
- NAT Hold
- EYPT Strong Buy
- Analyst Count
- NAT 2
- EYPT 8
- Target Price
- NAT $3.75
- EYPT $27.29
- AVG Volume (30 Days)
- NAT 2.9M
- EYPT 918.1K
- Earning Date
- NAT 11-29-2024
- EYPT 11-07-2024
- Dividend Yield
- NAT 15.84%
- EYPT N/A
- EPS Growth
- NAT N/A
- EYPT N/A
- EPS
- NAT 0.30
- EYPT N/A
- Revenue
- NAT $367,467,000.00
- EYPT $45,713,000.00
- Revenue This Year
- NAT N/A
- EYPT N/A
- Revenue Next Year
- NAT $11.19
- EYPT N/A
- P/E Ratio
- NAT $8.58
- EYPT N/A
- Revenue Growth
- NAT N/A
- EYPT 7.50
- 52 Week Low
- NAT $2.47
- EYPT $7.21
- 52 Week High
- NAT $4.64
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- NAT 30.03
- EYPT 41.68
- Support Level
- NAT $2.47
- EYPT $7.21
- Resistance Level
- NAT $2.65
- EYPT $8.21
- Average True Range (ATR)
- NAT 0.09
- EYPT 0.49
- MACD
- NAT 0.00
- EYPT -0.02
- Stochastic Oscillator
- NAT 23.26
- EYPT 42.82
About NAT Nordic American Tankers Limited
Nordic American Tankers Ltd owns and operates double hull crude oil tankers. It is an international tanker company that owns double-hull Suezmax tankers. It operates vessels in the spot market or on spot market-related charters pursuant to cooperative arrangements with third parties. The company's fleet consists of crude oil tankers, and all of its vessels are employed in the spot market. The company has only one type of vessel - Suezmax crude oil tankers. It operates in markets that are very competitive and based mainly on supply and demand.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.